These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 14983406

  • 1. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM, Prummel MF, Wiersinga WM.
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [Abstract] [Full Text] [Related]

  • 2. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I.
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [Abstract] [Full Text] [Related]

  • 3. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J, Kretowski A, Topolska J, Siewko K, Jakubczyk D, Szelachowska M, Mikita A, Kinalska I.
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum cytokines levels in Graves' disease.
    Al-Humaidi MA.
    Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
    [Abstract] [Full Text] [Related]

  • 6. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I, Horváth S, Balázs C.
    Eur J Med Res; 1996 Sep 20; 1(11):543-6. PubMed ID: 9438158
    [Abstract] [Full Text] [Related]

  • 7. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M.
    Clin Endocrinol (Oxf); 2006 Feb 20; 64(2):189-95. PubMed ID: 16430719
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct 20; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 9. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A, Sansone D, Coronella C, Conte M, Iorio S, Perrino S, Battaglia M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2005 Jan 20; 62(1):24-9. PubMed ID: 15638866
    [Abstract] [Full Text] [Related]

  • 10. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R.
    Arch Intern Med; 1990 May 20; 150(5):1098-101. PubMed ID: 1691908
    [Abstract] [Full Text] [Related]

  • 11. Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.
    Esfahanian F, Naimi E, Doroodgar F, Jadali Z.
    Iran J Allergy Asthma Immunol; 2013 May 15; 12(2):168-75. PubMed ID: 23754356
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
    Myśliwiec J, Kretowski A, Stepień A, Mirończuk K, Kinalska I.
    Med Sci Monit; 2002 Sep 15; 8(9):MT159-62. PubMed ID: 12218953
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy.
    Ozata M, Uckaya G, Bolu E, Corapcioglu D, Bingol N, Ozdemir IC.
    Med Sci Monit; 2001 Sep 15; 7(4):696-700. PubMed ID: 11433197
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
    Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, Roti E.
    Eur J Endocrinol; 2000 Aug 15; 143(2):197-202. PubMed ID: 10913938
    [Abstract] [Full Text] [Related]

  • 19. Serum interferon gamma levels in autoimmune thyroid disease.
    Matsubayashi S, Kasuga Y, Sakatsume Y, Akasu F, Volpé R.
    Clin Invest Med; 1990 Oct 15; 13(5):271-4. PubMed ID: 2125901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.